Shoemaker Daniel D
Chief Scientific Officer at FATE
- Sold, on record
- $6.7M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Mar 8, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- FATEFATE THERAPEUTICS INCChief Scientific Officer
Sales by reason
0
Routine
10
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Mar 8, 2021Unusual
Sold 25.5% of their holdings
$2M25,000 shares at $81.73
- Jan 11, 2021Plan not stated
Sold 10.2% of their holdings
$1.1M9,482 shares at $114.95
- Nov 16, 2020Plan not stated
Sold 21.2% of their holdings
$1.3M25,000 shares at $51.83
- Sep 14, 2020Plan not stated
Sold 17.5% of their holdings
$908k25,000 shares at $36.30
- Jan 8, 2020Plan not stated
Sold 3.8% of their holdings
$118k5,700 shares at $20.70
- Dec 30, 2019Plan not stated
Sold 16.8% of their holdings
$487k25,000 shares at $19.49
- Oct 15, 2019Plan not stated
Sold 8.7% of their holdings
$169k11,800 shares at $14.29
- Jun 27, 2019Plan not stated
Sold 8.4% of their holdings
$253k12,500 shares at $20.21
- Mar 28, 2019Plan not stated
Sold 8.4% of their holdings
$212k12,500 shares at $16.94
- Oct 16, 2017Plan not stated
Sold 12.7% of their holdings
$51k13,225 shares at $3.87
10 of 11
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2021 | Mar 9, 2021 | FATE | Chief Scientific Officer | Sold | 25,000 | $81.73 | $2M | 73,020 | SEC |
| Jan 20, 2021 | Jan 22, 2021 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 5,481 | 5,481 | SEC | ||
| Jan 20, 2021 | Jan 22, 2021 | FATE | Chief Scientific Officer | Awarded | 14,411 | 98,020 | SEC | ||
| Jan 11, 2021 | Jan 12, 2021 | FATE | Chief Scientific Officer | Sold | 9,482 | $114.95 | $1.1M | 83,609 | SEC |
| Nov 16, 2020 | Nov 16, 2020 | FATE | Chief Scientific Officer | Sold | 25,000 | $51.83 | $1.3M | 93,091 | SEC |
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Scientific Officer | Sold | 25,000 | $36.30 | $908k | 118,091 | SEC |
| Jan 8, 2020 | Jan 10, 2020 | FATE | Chief Scientific Officer | Sold | 5,700 | $20.70 | $118k | 143,091 | SEC |
| Jan 8, 2020 | Jan 10, 2020 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 90,000 | 90,000 | SEC | ||
| Jan 8, 2020 | Jan 10, 2020 | FATE | Chief Scientific Officer | Awarded | 25,000 | 148,791 | SEC | ||
| Dec 30, 2019 | Jan 2, 2020 | FATE | Chief Scientific Officer | Sold | 25,000 | $19.49 | $487k | 123,791 | SEC |
| Dec 30, 2019 | Jan 2, 2020 | FATE | Chief Scientific Officer | Exercised or settledStock Option (right to buy) | 25,000 | 98,800 | SEC | ||
| Dec 30, 2019 | Jan 2, 2020 | FATE | Chief Scientific Officer | Exercised options | 25,000 | $2.90 | $73k | 148,791 | SEC |
| Oct 15, 2019 | Oct 16, 2019 | FATE | Chief Scientific Officer | Sold | 11,800 | $14.29 | $169k | 123,791 | SEC |
| Jun 27, 2019 | Jun 28, 2019 | FATE | Chief Scientific Officer | Sold | 12,500 | $20.21 | $253k | 135,591 | SEC |
| Jun 27, 2019 | Jun 28, 2019 | FATE | Chief Scientific Officer | Exercised or settledStock Option (right to buy) | 12,500 | 123,800 | SEC | ||
| Jun 27, 2019 | Jun 28, 2019 | FATE | Chief Scientific Officer | Exercised options | 12,500 | $2.90 | $36k | 148,091 | SEC |
| Mar 28, 2019 | Mar 29, 2019 | FATE | Chief Scientific Officer | Sold | 12,500 | $16.94 | $212k | 135,591 | SEC |
| Mar 28, 2019 | Mar 29, 2019 | FATE | Chief Scientific Officer | Exercised or settledStock Option (right to buy) | 12,500 | 136,300 | SEC | ||
| Mar 28, 2019 | Mar 29, 2019 | FATE | Chief Scientific Officer | Exercised options | 12,500 | $2.90 | $36k | 148,091 | SEC |
| Jan 7, 2019 | Jan 9, 2019 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 135,000 | 135,000 | SEC | ||
| Jan 7, 2019 | Jan 9, 2019 | FATE | Chief Scientific Officer | Awarded | 45,000 | 135,591 | SEC | ||
| Jan 16, 2018 | Jan 17, 2018 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 186,000 | 186,000 | SEC | ||
| Oct 16, 2017 | Oct 17, 2017 | FATE | Chief Scientific Officer | Sold | 13,225 | $3.87 | $51k | 90,591 | SEC |
| Jan 4, 2017 | Jan 6, 2017 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 150,000 | 150,000 | SEC | ||
| Jan 8, 2016 | Jan 12, 2016 | FATE | Chief Scientific Officer | AwardedStock Option (right to buy) | 148,800 | 148,800 | SEC | ||
| Jan 8, 2016 | Jan 12, 2016 | FATE | Chief Scientific Officer | Awarded | 9,388 | 103,816 | SEC | ||
| Oct 15, 2015 | Oct 16, 2015 | FATE | Chief Scientific Officer | Awarded | 66,000 | 94,428 | SEC | ||
| Jan 5, 2015 | Jan 7, 2015 | FATE | Chief Research Officer | AwardedStock Option (right to buy) | 70,000 | 70,000 | SEC | ||
| Jan 5, 2015 | Jan 7, 2015 | FATE | Chief Research Officer | Awarded | 2,466 | 28,428 | SEC | ||
| Mar 31, 2014 | Apr 2, 2014 | FATE | Chief Technology Officer | Sold | 8,653 | $9.86 | $85k | 25,962 | SEC |
| Jan 9, 2014 | Jan 10, 2014 | FATE | Chief Technology Officer | AwardedStock Option (right to buy) | 85,000 | 85,000 | SEC |
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2021 | Mar 9, 2021 | FATE | Chief Scientific Officer | Form 4 sale | 25,000 | $2M | 25.5% | Unusual | SEC |
| Jan 11, 2021 | Jan 12, 2021 | FATE | Chief Scientific Officer | Form 4 sale | 9,482 | $1.1M | 10.2% | Plan not stated | SEC |
| Nov 16, 2020 | Nov 16, 2020 | FATE | Chief Scientific Officer | Form 4 sale | 25,000 | $1.3M | 21.2% | Plan not stated | SEC |
| Sep 14, 2020 | Sep 16, 2020 | FATE | Chief Scientific Officer | Form 4 sale | 25,000 | $908k | 17.5% | Plan not stated | SEC |
| Jan 8, 2020 | Jan 10, 2020 | FATE | Chief Scientific Officer | Form 4 sale | 5,700 | $118k | 3.8% | Plan not stated | SEC |
| Dec 30, 2019 | Jan 2, 2020 | FATE | Chief Scientific Officer | Form 4 sale | 25,000 | $487k | 16.8% | Plan not stated | SEC |
| Oct 15, 2019 | Oct 16, 2019 | FATE | Chief Scientific Officer | Form 4 sale | 11,800 | $169k | 8.7% | Plan not stated | SEC |
| Jun 27, 2019 | Jun 28, 2019 | FATE | Chief Scientific Officer | Form 4 sale | 12,500 | $253k | 8.4% | Plan not stated | SEC |
| Mar 28, 2019 | Mar 29, 2019 | FATE | Chief Scientific Officer | Form 4 sale | 12,500 | $212k | 8.4% | Plan not stated | SEC |
| Oct 16, 2017 | Oct 17, 2017 | FATE | Chief Scientific Officer | Form 4 sale | 13,225 | $51k | 12.7% | Plan not stated | SEC |
| Mar 31, 2014 | Apr 2, 2014 | FATE | Chief Technology Officer | Form 4 sale | 8,653 | $85k | 25.0% | Plan not stated | SEC |